Bank of America (OM) reports 3.5% beneficial stake in Outset Medical shares

Rhea-AI Filing Summary

Bank of America Corporation reported beneficial ownership of 666,596 shares of Outset Medical, Inc. common stock, representing 3.5% of the class based on 18,797,000 shares outstanding as of June 30, 2026. All voting and dispositive authority is reported as shared, with no sole power to vote or dispose of any shares.

The filing attributes shared voting power over 666,542 shares and shared dispositive power over 666,587 shares. The position is held through Bank of America Corporation and its wholly owned subsidiaries BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, and Merrill Lynch Pierce Fenner & Smith, Inc., and is characterized as ownership of 5 percent or less of the class.

Key Figures

Beneficially owned shares: 666,596 shares Percent of class: 3.5% Shared voting power: 666,542 shares +2 more

5 metrics

Beneficially owned shares 666,596 shares Outset Medical common stock beneficially owned by Bank of America Corporation

Percent of class 3.5% Portion of Outset Medical common stock class beneficially owned

Shared voting power 666,542 shares Shares over which Bank of America has shared power to vote or direct the vote

Shared dispositive power 666,587 shares Shares over which Bank of America has shared power to dispose or direct disposition

Shares outstanding baseline 18,797,000 shares Outset Medical shares outstanding as of June 30, 2026, used for ownership calculation

Key Terms

beneficial ownership, shared voting power, shared dispositive power, parent holding company, +1 more

5 terms

beneficial ownership financial

"The beneficial ownership calculation relies on the 18,797,000 outstanding shares disclosed"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"Shared Voting Power 666,542.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 666,587.00"

parent holding company financial

"If a parent holding company has filed this schedule, pursuant to (ii)(G)"

broker dealer registered under section 15 of the Act regulatory

"a broker dealer registered under section 15 of the Act"

FAQ

What stake does Bank of America report in Outset Medical (OM)?

Bank of America reports beneficial ownership of 666,596 shares of Outset Medical common stock, representing 3.5% of the outstanding class based on 18,797,000 shares reported as of June 30, 2026.

How much voting power does Bank of America have in Outset Medical (OM)?

Bank of America reports no sole voting power and shared voting power over 666,542 shares of Outset Medical common stock, reflecting its ability to vote or direct the vote only on a shared basis.

What dispositive power does Bank of America report over OM shares?

Bank of America reports no sole dispositive power and shared dispositive power over 666,587 shares of Outset Medical common stock, indicating authority to dispose or direct disposition solely on a shared basis.

Which Bank of America subsidiaries are involved in the Outset Medical (OM) holding?

The position is reported on behalf of Bank of America Corporation and wholly owned subsidiaries BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, and Merrill Lynch Pierce Fenner & Smith, Inc..

Is Bank of America a 5% beneficial owner of Outset Medical (OM)?

No. Bank of America reports 3.5% of the class of Outset Medical common stock and explicitly characterizes its position as ownership of 5 percent or less of the class.

What share count did Bank of America use to calculate its 3.5% OM stake?

The 3.5% beneficial ownership is based on 18,797,000 outstanding shares of Outset Medical common stock, as reported by the issuer for June 30, 2026 in its Form 10-Q filed August 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 12:35 PM Accepted by SEC EDGAR 08/12/2026 - 12:34 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Outset Medical, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

690145206

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 690145206

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 666,542.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 666,587.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

666,596.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.5 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 18,797,000 outstanding shares disclosed in the Form 10-Q by the issuer on August 6, 2026, which reports share totals as of June 30, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Outset Medical, Inc.
(b)	Address of issuer's principal executive offices: 3052 ORCHARD DRIVE, 3052 ORCHARD DRIVE, SAN JOSE, CALIFORNIA, 95134.
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 690145206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 666,596.00
(b)	Percent of class: 3.5%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 666,542.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 666,587.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); and Merrill Lynch Pierce Fenner & Smith, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	/s/ Monica Yako
Name/Title:	Authorized Signatory
Date:	08/12/2026